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1. Introduction 
We have proposed [ 1,2] that thyroid hormones act 
in vivo to stimulate mitochondrial state 4 [3] respira- 
tory rates by inhibiting an ohmic component of the 
conductance of the inner mitochondrial membrane 
and thus elevating &H’ and activating non-ohmic 
conductance pathways. Ca2+ recycling across the 
mitochondrial membrane necessitates respiratory 
driven H’ efflux to maintain the steady state and 
involves independent influx and efflux mechanisms 
[4] which exhibit ohmic [5] and non-ohmic proper- 
ties [6]. Several hormones including insulin [7], glu- 
cagon [8-l 0] and the catecholamines [lo] have 
been shown to influence these Ca2+ fluxes. Therefore, 
reports that Ca ‘+ efflux is enhanced by thyroid hor- 
mones added in vitro [ 11 ,121 suggested that Ca2+ 
efflux might be the non-ohmic pathway which was 
stimulated by our in vivo thyroxine treatment. We 
now report that this treatment does stimulate Ca2+ 
efflux although there are important differences 
between the in vitro and in vivo actions of thyroxine. 
However, we also show that the extra Ca2+ cycling 
does not contribute significantly to the increased res- 
piration resulting from thyroxine treatment in vivo. 
2. Methods 
Male Wistar rats (250 g) were injected with either 
8 mg thyroxine/kg body wt or isotonicsahne, and after 
Abbreviutions: ApH’, mitochondrial proton electrochemical 
potential gradient; A\Ir, transmembrane lectrical potential; 
CCFP, carbonylcyanide p-trifluoromethoxyphenylhydrazone; 
EGTA, ethylenebis (oxonitrilo) tetraacetic acid 
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24 hliver mitochondria were isolated as in [ 1,2]. Protein 
was assayed by a biuret method [13]. Mitochondrial 
Ca2+ fluxes were determined in one of two media: 
medium (A) contained 80 mM sucrose, 20 mM KCl, 
10 mM PO4 (as Tris-P04, pH 7.0), 5 mM MgC12, and 
5 mM Tris-succinate; (B) was identical with (A), 
except for the absence of KC1 and MgCl,, since Mg2+ 
[ 141 and K’ [ 151 modulate Ca2+ transport. Mitochon- 
dria (2 mg protein/ml) were incubated in the presence 
of 4sCa2+ (0.6 pCi/ml) as CaCl, at either 19 or 45 na- 
toms Ca2+/mg protein. The final volume was 1.6 ml. 
At 0.75-4 min after the addition of the mitochon- 
dria, 0.2 ml samples were removed and spun at 
10 000 X g for 0.5 mm in a Beckman microfuge. The 
supernatant was immediately poured off and 0.05 ml 
was taken to 1.5 ml with scintillation fluid (Fisoflor 
‘mpc’, Fisons, Loughborough) and counted in a 
Beckman LS-230. For each experiment, endogenous 
non-radioactive Ca2+ was determined [2] after adding 
0.5 ml stock mitochondrial suspension to 0.5 ml 2 M 
perchloric acid. Full exchange ability of radioactive 
with non-radioactive pools of Ca2+ was assumed. 
EGTA-induced Ca2+ efflux was estimated follow- 
ing the addition of 4 PM ruthenium red and 2 mM 
EGTA [ 161 to the medium 1 mm after the mitochon- 
dria were added. Control experiments (not shown) 
indicated that Ca2+ uptake was inhibited by >98% 
during the time course of our incubations. The con- 
tribution of Ca2+ cycling to respiratory rates was esti- 
mated by assuming Ca2+ efflux via Ca2+/2 H’ antiport 
and Ca2+ influx by Ca2” uniport [6], and a succinate 
supported H’:O stoichiometry of 6 [17]. 
Respiratory rates and ADP:O ratios were deter- 
mined as in [ 1,2]. All incubations were stirred, and 
maintained at 30°C. 
CCFP, ADP and ruthenium red were supplied by 
Sigma, Kingston Upon Thames. Ruthenium red was 
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purified [ 181. 45CaC12 was purchased from Radio- 
chemical Centre, Amersham. 
3. Results and discussion 
With mitochondria from euthyroid and thyroxine- 
treated rats, respiratory rates were unaffected when 
ruthenium red and EGTA were used to inhibit recy- 
cling of endogenous Ca2+ across the mitochondrial 
membrane (table 1). Thus our thyroxine treatment 
increased respiratory rates by up to 88% when recy- 
cling of endogenous Ca2+ was not making a significant 
contribution. 
We also noted (table 1) that CCFP-stimulated respi- 
ratory rates were enhanced by thyroxine treatment, 
due presumably to a direct effect of the hormone upon 
the respiratory enzymes. It is not clear to what extent 
such a mechanism might be responsible for the stimu- 
lation of state 3 respiratory rate, which may be further 
improved by a hormone-mediated increase in the 
uptake of ADP and phosphate by the mitochondria 
[ 1,2,19]. Our measurements of Cal+ efflux were made 
using <50 natoms Ca’+/mg protein since above this 
level the rate of Ca2+ efflux increases dramatically 
[20]. It has been suggested [20] that at <.50 natoms 
Ca2+/protein, Ca2+ efflux occurred at a relatively slow 
rate because the matrix Ca2+ activity was significantly 
diminished as a consequence of extensive precipita- 
tion and binding of this cation. We disagree with this 
explanation since, as pointed out in [21], it is difficult 
to understand how the matrix Ca2+ activity could be 
low under these conditions since retention of the ion 
is almost totally dependent upon A* and virtually 
all the Ca2+ is lost from the mitochondria within sec- 
onds of the addition of CCFP (e.g., table 2). Perhaps 
the increased rate of Ca2+ efflux following addition 
of X0 natoms Ca’+/mg protein [20], reflects some 
destabilization of the mitochondrial membrane with 
a consequent reduction in the value of A\k. Under 
such conditions, Ca2+ leaves the mitochondria via a 
reversal of the Ca2+ influx carrier [21], a process ap- 
parently insensitive to ruthenium red [22], (line 4 in, 
table 2). We have also observed that thyroxine treat- 
ment in vivo, appears to protect against the destabi- 
lizing effects of the higher Ca2+ levels [2] and to 
avoid these complicating effects, we have carried out 
our experiments with <50 natoms Ca’+/mg protein. 
Our data (lines l-3 in table 2) indicate that thy- 
roxine treatment in vivo does increase the rate of Ca2+ 
efflux from isolated mitochondria by 27-5 1%. The 
effect cannot be a consequence of the hormone un- 
coupling the mitochondria since the thyroxine treat- 
ment does not modify ADP:O ratios (table 1). This 
conclusion is further substantiated by the increases we 
have observed in &H’ and ion uptake [ 1,2]. In the 
steady state, the effect of Ca2+ efflux (table 2) on 
respiratory rate (section 2) would be <l natom 
Table 1 
The effect of in vivo thyroxine treatment upon respiratory rates and ADP:O ratios of isolated mitochondria, and the 
influence of ruthenium red plus EGTA 
ADP:O Respiratory rate (natoms 0 mg protein“ min-‘) 











1.88 f 0.2 (3) 13.5 * 0.9 (7) 73.2 + 3.2 (7) 59.4 f 4.7 (4) 
1.89 r 0.17 (3) 12.6 r 1.3 (4) 80.6 + 11.2 (3) n.d. 
1.85 f 0.16 (3) 25.4 f 0.8 (7) 106.9 + 9.3 (7) 98.4 f 3.9 (4) 
1.85 f 0.17 (3) 23:8 + 1.7 (4) 123.0 r 20.7 (3) n.d. 
Incubation conditions: medium (A) containing 2 mg mitochondrial protein/ml. ADP (0.2 pmol/mg protein) added at 2 min. 
Uncoupled mitochondria were those treated with 0.3 MM CCFP. Where present, 4 PM ruthenium red and 2 mM EGTA were added 
immediately after the mitochondria. Data include standard errors of the mean, and the number of mitochondrial preparations in 
parentheses; n.d., not determined 
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Table 2 
The effect of in vivo and in vitro thyroxine treatment upon mitochondrial Ca2+ fluxes 
and respiratory rates under various conditons 




-RR +RR -RR +RR 
ACa’+ @atoms . mg protein-‘. min“) 
1 A 19 -0.08 -1.55 -0.07 -1.97 
2 A 45 -0.18 -2.2 +0.09 -3.04 
3 B 19 -0.12 -1.95 +0.08 -2.95 
4 B+CCFP 19 -55 -58.2 -69.7 -79.4 
5 B + Thyroxine 19 -57.2 _ 4.76 nd. n.d. 
Respiratory rate (natoms 0 . mg protein-’ . min*‘) 
6 A 19 16.4 16.4 26.1 31 
7 A 45 17.6 19.5 35.3 33.4 
8 B 19 18.8 19.9 28.4 30.8 
9 B + WFP 19 50.1 48.9 90.5 70.5 
10 B + Thyroxine 19 53.0 25.6 nd. n.d. 
Incubation conditions: medium (A) or (B) as indicated. Where present, CCFP at 0.3 PM, thyroxine at 
100 MM. RR represents presence of 4 PM ruthenium red plus 2 mM EGTA. Negative ACaa+ indicates 
loss from ~tochondria. - is inserted where rapidity of flux is such that it exceeds the ability of our 
technique to record it accurately. AR respiratory rates are means from two mitochondrial preparations; 
2 or 3 preparations were used to record Ca2* fhtxes; n.d., not determined 
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0 , mg protein-’ . min -l. Moreover, the different rates 
of Ca’* efflux of the two populations of ~tochondria 
account for respiratory differences of GO.3 natoms 
0 . mg protein-“. mm-‘, i.e., 3% of the respiratory 
e~ancement due to thyroxine treatment (lines 3,8 
in table 2). It is unlikely that we underestimated the 
extent of Ca2” efflux, because of any inhibition by 
ru~e~urn red, since the latter did not inhibit respi- 
ratory rate (lines 6-8 in table 2). 
Our data may be compared with those in [ 121; fol- 
lowing the accumulation by heart ~tochondria of 20 
natoms Ca/mg protein in the absence of Mg2+, 
ruthenium red and -50 nmol thyroxine/mg protein 
were added. The iatter induced a >lO-fold stimula- 
tion in the rate of Ca2+ efflux and a similar phenom- 
enon was observed in liver mitochondria [ 111. We 
have confirmed this in vitro action of thyroxine 
(compare lines 3 and 5 in table 2) but the interpreta- 
tion of these results is likely to be complicated, For 
instance, in the absence of ru~enium red, the thyrox- 
ine-induced increase in respiratory rate (line 10) was 
not further enhanced by CCFP (not shown). More- 
over, the rate of Ca2* efflux from mitochondria treated 
with thyroxine in vitro (line 5) was similar to that 
from uncoupled mitochondria (line 4). Thus thyrox- 
ine in vitro may uncouple the ~to~hondria 1231 in- 
ducing a reversal of the Ca2’ influx mechanism [2 11. 
Alternatively, if the hormone activates the indepen- 
dent Ca2+ efflux carrier, subsequent Ca” recycling 
may uncouple the organelles. In any case, these events 
differ from the effects of thyroxine treatment in vivo 
(see above), Note also that ruthe~um red largely 
reverses or inhibits the increases in rates of Ca2+ efflux 
and respiration caused by thyroxine in vitro (lines 5 
and 10). In conclusion, thyroxine treatment in vivo 
stimulates Ca2+ efflux in contrast to the inhibitory 
effect of glucagon and catecholamines [lo] on this 
process. However, the thyroid hormone effects on 
Ca2+ efflux do not appear to contribute significantly 
to the enhancement of respiratory rate by the hor- 
mone. 
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